Related Experiment Videos
Gene therapy and pharmaceutical modulation of apoptosis
1Department of Medicine, University of Minnesota Medical School, Veterans Affairs Medical Center, Minneapolis, 55417, USA. shekh003@maroon.tc.umn.edu
Abstract:
Apoptosis is detectable in cardiovascular disease in various forms. Although the methods to detect apoptosis need improvement, and its magnitude is not known clearly, there is sufficient evidence to postulate that it might be important in progression of disease. Clinicians now have some specific compounds that can be used to modulate apoptosis. The preliminary data suggest that we can modulate apoptosis in animal models and that this is associated with obvious benefits in terms of tissue salvage and possibly improved function. There are no human data as yet. Many questions must be addresses before undertaking human studies. Despite these shortcomings, there is a tremendous potential for apoptotic modulation in preventing or ameliorating cardiovascular disease in the near future.
Insights
Apoptosis, programmed cell death, plays a role in cardiovascular disease progression. Modulating apoptosis in animal models shows promise for tissue salvage and improved function, suggesting future therapeutic potential.
Area of Science:
- Cardiovascular Medicine
- Cell Biology
- Pathophysiology
Background:
- Apoptosis (programmed cell death) is observed in cardiovascular disease.
- Current methods for detecting apoptosis require enhancement, and its precise role in disease progression is not fully elucidated.
- Evidence suggests apoptosis may significantly contribute to the advancement of cardiovascular conditions.
Purpose of the Study:
- To explore the potential of modulating apoptosis as a therapeutic strategy for cardiovascular disease.
- To evaluate the preliminary efficacy of apoptosis modulation in preclinical models.
Main Methods:
- Review of existing evidence on apoptosis in cardiovascular disease.
- Analysis of preliminary data from animal models investigating the effects of apoptosis modulation.
- Assessment of therapeutic compounds designed to modulate apoptosis.
Main Results:
- Preliminary data indicate that apoptosis can be modulated in animal models of cardiovascular disease.
- Apoptosis modulation in these models was associated with improved tissue salvage and functional outcomes.
- Specific compounds for apoptosis modulation are available for clinical consideration.
Conclusions:
- Apoptosis modulation demonstrates significant potential for preventing or ameliorating cardiovascular disease.
- Further research, including human studies, is necessary to address current limitations and fully realize therapeutic benefits.
- Despite the need for more data, targeting apoptosis represents a promising future direction in cardiovascular medicine.